Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing need to comply with regulatory requirements
3.2.1.2 Surging demand for faster approval process for breakthrough drugs and devices
3.2.1.3 Rising number of clinical trials
3.2.1.4 Increasing regulatory complexity
3.2.2 Industry pitfalls & challenges
3.2.2.1 Data security and privacy concerns
3.2.2.2 Lack of standardization
3.3 Growth potential analysis
3.4 Porter's analysis
3.4.1 Supplier power
3.4.2 Buyer power
3.4.3 Threat of new entrants
3.4.4 Threat of substitutes
3.4.5 Industry rivalry
3.5 PESTEL analysis
3.6 Service price analysis
3.7 Regulatory landscape
3.8 Technological landscape
3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Services, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Product registration & clinical trial application
5.3 Regulatory consulting/strategic services
5.4 Submission management
5.5 Legal representation
5.6 Regulatory writing & publishing
5.7 Other services
Chapter 6 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Oncology
6.3 Neurology
6.4 Cardiology
6.5 Immunology
6.6 Other indications
Chapter 7 Market Estimates and Forecast, By Product Stage, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Preclinical
7.3 Clinical
7.4 Post market authorization (PMA)
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical companies
8.3 Biotechnology companies
8.4 Medical device companies
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Accell Clinical Research, LLC
10.2 Charles River Laboratories
10.3 Clinilabs, Inc.
10.4 Freyr
10.5 Genpact
10.6 ICON plc
10.7 Labcorp Drug Development
10.8 PAREXEL International Corporation
10.9 ProPharma Group
10.10 Proventa International
10.11 Thermo Fisher Scientific Inc.
